AlgiPharma now features on the Cystic Fibrosis Foundation (CFF) drug development pipeline. The CFF interactive drug development pipeline shows the progress of potential CF treatments through the different phases of clinical research. AlgiPharma’s listing in the pipeline of CF drug development reflects the progress and potential for its mucus altering and biofilm disruption alginate oligomer therapy.
Click here to find more information about the CFF interactive drug development pipeline.
Yngvar P. Berg, CEO; firstname.lastname@example.org
May 4th 2016